Kevin Batterbee
Psychiatry · Colorado Springs, CONPI 1427112572
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.9% of the total across 112 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 17 manufacturers, the largest accounting for just 20.0% — the pattern of someone who eats at a lot of different presentations. 2024 is the largest year on record at $1,246, 5.2 times the $240 reported in 2019. Among psychiatry clinicians in CO with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 112 payments — averaging $22.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Neurocrine Biosciences, Inc.$515
- Lundbeck LLC$421
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$323
- AbbVie$277
- Idorsia Pharmaceuticals US Inc$187
- Johnson & Johnson$184
- plus $666 from 11 others
What the payments were for
- Food & beverage$2,54799%
- Education$271%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Neurocrine Biosciences, Inc. | 20 | $515 |
| Lundbeck LLC | 17 | $421 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 11 | $323 |
| AbbVie | 12 | $277 |
| Idorsia Pharmaceuticals US Inc | 11 | $187 |
| Johnson & Johnson | 4 | $184 |
| Sunovion Pharmaceuticals Inc. | 15 | $182 |
| Alkermes, Inc. | 6 | $97 |
| E.r. Squibb & Sons, L.L.C. | 3 | $95 |
| Noven Therapeutics, LLC | 3 | $69 |
| Teva Pharmaceuticals USA, Inc. | 2 | $54 |
| Corium, LLC | 2 | $49 |
| Bausch Health US, LLC | 2 | $42 |
| Neuronetics, Inc. | 1 | $23 |
| Axsome Therapeutics, Inc. | 1 | $22 |
| Adlon Therapeutics L.p. | 1 | $21 |
| Alfasigma USA, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,575 in reported general payments places this provider in the 90th percentile of 559 psychiatry providers in Colorado.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ziprasidone Hcl | 28 | $379 |
| Trazodone Hcl | 21 | $284 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 24 | $236 |
| Naltrexone Hcl | 13 | $235 |
| Aripiprazole | 17 | $169 |
| Zolpidem Tartrate | 13 | $134 |
| Bupropion Hcl SrBupropion Hcl | 14 | $59 |
| Mirtazapine | 15 | $50 |
Paid to pharmacies, not to this prescriber.
Other psychiatry in Colorado Springs
- Jonathan CoveyColorado Springs$8K
- Kwang-Soo ParkColorado Springs$3K
- Kevin SnyderColorado Springs$3K
- Frederick MichelColorado Springs$3K
- Peter MarlinColorado Springs$2K
- Ian GeisColorado Springs$2K
- Monica NicholsColorado Springs$2K
- Kevin KilimannColorado Springs$2K
- Brandon BakerColorado Springs$2K
- John HardyPueblo$828K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.